The Latin America, Middle East and Africa Wound Debridement Market would witness market growth of 8.9% CAGR during the forecast period (2022-2028).
Rising economies and demographics of many developed and developing nations have resulted in the state governments investing more in the advancement and sustainability of the healthcare industry in their nations. The continual rise and development of healthcare infrastructure and expenditure, improving reimbursement policies, and provision of state help have helped in the development of cost-effective wound debridement products.
Throughout the world, chronic wound prevalence is rising, primarily fuelled by increasing diabetic and aging populations as well as the rising incidences of disease and conditions like obesity. These factors, along with several other situations like radiation therapy’s late effects, further aggravate conditions that increase the chances of acquiring a chronic wound.
Additionally, it has been found that ordinary people with chronic wounds also suffer from three or four chronic conditions like cardiovascular diseases (CVD), peripheral arterial disease (PAD), and chronic obstructive pulmonary disorder (COPD). Furthermore, the growing awareness of people to lead a healthy life has shifted their focus to adopting a holistic approach to attain improved well-being and health.
High Body Mass Index (BMI) is considered to be the prominent cause of diabetes, primarily type 2. This is specifically true in the Latin American region's case. The high BMI of a larger proportion of population has subsequently increased the prevalence of diabetes and diabetes-associated mortality, which has been found to be among the highest in the world. Consequently, the high incidences of diabetes have become a significant threat to the economy, health systems, and population health in many nations of the region.
The Brazil market dominated the LAMEA Wound Debridement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $112.9 million by 2028. The Argentina market is experiencing a CAGR of 9.5% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 8.7% during (2022 - 2028).
Based on Mode of Purchase, the market is segmented into Prescription, Over The Counter and Others. Based on Product, the market is segmented into Medical Gauzes, Gels, Surgical Devices, Ultrasonic Devices, Ointments & Creams and Others. Based on Method, the market is segmented into Surgical, Autolytic, Enzymatic, Mechanical and Others. Based on Wound Type, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Burn Wounds and Venous Leg Ulcers & Others. Based on End-use, the market is segmented into Hospitals, Homecare and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Wound Debridement Market is Predict to reach $6.1 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Medtronic PLC, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson & Johnson (Ethicon, Inc.), Baxter International, Inc., and Molnlycke Health Care AB.
By Mode of Purchase
By Product
By Method
By Wound Type
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 